ISSN 1671-5411 CN 11-5329/R
Antonin Negers, Jacques Boddaert, Lucie Mora, Jean-Louis Golmard, Laura Moisi, Ariel Cohen, Jean-Philippe Collet, Alice Breining. Determinants of invasive strategy in elderly patients with non-ST elevation myocardial infarction. J Geriatr Cardiol 2017; 14(7): 465-472. doi: 10.11909/j.issn.1671-5411.2017.07.001
Citation: Antonin Negers, Jacques Boddaert, Lucie Mora, Jean-Louis Golmard, Laura Moisi, Ariel Cohen, Jean-Philippe Collet, Alice Breining. Determinants of invasive strategy in elderly patients with non-ST elevation myocardial infarction. J Geriatr Cardiol 2017; 14(7): 465-472. doi: 10.11909/j.issn.1671-5411.2017.07.001

Determinants of invasive strategy in elderly patients with non-ST elevation myocardial infarction

doi: 10.11909/j.issn.1671-5411.2017.07.001
Funds:

None

  • Received Date: 2017-02-15
  • Rev Recd Date: 2017-05-06
  • Publish Date: 2017-07-28
  • Background Knowledge gaps across literature prevent current guidelines from providing the profile of elderly patients most likely to derive benefit from invasive strategy (IS) in non ST-elevation myocardial infarction (NSTEMI). Furthermore, the benefit of IS in a real-world elderly population with NSTEMI remains unclear. The aims of this study were to determine factors that lead the cardiologist to opt for an IS in elderly patients with NSTEMI, and to assess the impact of IS on the 6-month all-cause mortality. Methods This multicenter prospective study enrolled all consecutive patients aged ≥ 75 years old who presented a NSTEMI and were hospitalized in cardiology intensive care unit between February 2014 and February 2015. Patients were compared on the basis of reperfusion strategy (invasive or conservative) and living status at six months, in order to determine multivariate predictors of the realization of an IS and multivariate predictors of 6-month mortality. Results A total of 141 patients were included; 87 (62%) underwent an IS. The strongest independent determinants of IS were younger age [odds ratio (OR): 0.85, 95%-confidence interval (CI): 0.78 ± 0.92; P P = 0.002). IS was not significantly associated with 6-month survival (OR: 0.80, 95%CI: 0.27–2.38; P = 0.69). Conclusions In real-world elderly patients with NSTEMI, younger patients with fewer comorbidities profited more often from an IS. However, IS did not modify 6-month all-cause mortality.
  • loading
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Article Metrics

    Article views (855) PDF downloads(990) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return